About
Review and discuss research regarding non-hepatic malignancy in the candidate, the donor or the recipient, including selection criteria/indications, prognostic models, surveillance strategies, novel therapies and management.
Gain insight into innovations that lead to improvement in the field of liver transplantation in candidates or donors with a history of malignancy, and in recipients with de novo cancer, both in adult and pediatric populations.
Agenda
  • Incidence and risk factors - Kymberly Watt, MD
  • Screening strategies after liver transplantation - José Ignacio Herrero, MD
  • Treatment for solid tumors - Gonzalo Sapisochin, MD
  • Treatment for post-transplant lymphoproliferative disorders (PTLD) - Dok Hyun Yoon, MD
  • Q&A
  • Presidential address - Claus Niemann, MD
Presenters
1610713231-26560a06854ac97d
Gonzalo Crespo, MD
Moderator
Hospital Clinic de Barcelona, Barcelona, Spain
1610713313-c10ad95d8972b48c
Mark Ghobrial, MD, PhD, FRCS
Moderator
Houston Methodist Hospital, Houston, USA
1610713325-636d53c78fc111a6
Kymberly Watt, MD
Speaker
Mayo Clinic, Rochester, USA
1610713333-d14c2cb5ba90f1a8
José Ignacio Herrero, MD
Speaker
University Clinic of Navarra, Pamplona, Spain
1610713343-c8f6042d858984a4
Gonzalo Sapisochin, MD
Speaker
UHN - Toronto General Hospital, Toronto, Canada
1610713356-170218d3c475494b
Dok Hyun Yoon, MD
Speaker
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1599565458-bc788b6fd54cb57f
Claus Niemann, MD
Speaker
UCSF, San Francisco, USA